Literature DB >> 15229983

Giant cell arteritis in a patient taking etanercept and methotrexate.

Margaret Seton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229983

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

Review 1.  Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?

Authors:  Cengiz Korkmaz; Pınar Yıldız
Journal:  Eur J Rheumatol       Date:  2017-02-24

Review 2.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

Review 3.  Biologic Therapy for the Treatment of Giant Cell Arteritis.

Authors:  Rochella A Ostrowski; Melissa R Bussey; Rodney Tehrani; Walter Jay
Journal:  Neuroophthalmology       Date:  2014-04-02

4.  Takayasu's arteritis occurring under TNF-α blockers: a new paradoxical effect?

Authors:  Leila Souabni; Kaouther Ben Abdelghani; Saoussen Jradi; Leith Zakraoui
Journal:  BMJ Case Rep       Date:  2014-11-24

5.  Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis.

Authors:  S K Metyas; R M Tadros; D G Arkfeld
Journal:  Rheumatol Int       Date:  2008-09-02       Impact factor: 2.631

Review 6.  Vasculitis induced by tumor necrosis factor-targeted therapies.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

Review 7.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.